BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24289923)

  • 1. The BRCA1/BARD1-interacting protein OLA1 functions in centrosome regulation.
    Matsuzawa A; Kanno S; Nakayama M; Mochiduki H; Wei L; Shimaoka T; Furukawa Y; Kato K; Shibata S; Yasui A; Ishioka C; Chiba N
    Mol Cell; 2014 Jan; 53(1):101-14. PubMed ID: 24289923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OLA1 in centrosome biology alongside the BRCA1/BARD1 complex: looking beyond centrosomes.
    Gomez V; Hergovich A
    Mol Cell; 2014 Jan; 53(1):3-5. PubMed ID: 24411079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of Brca1-interacting factor Ola1 in female mice induces tumors with estrogen suppressible centrosome amplification.
    Yoshino Y; Ogoh H; Iichi Y; Sasaki T; Yoshida T; Ichimura S; Nakayama M; Xi W; Fujita H; Kikuchi M; Fang Z; Li X; Abe T; Futakuchi M; Nakamura Y; Watanabe T; Chiba N
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167138. PubMed ID: 38537683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulations reveal the effect of mutations in the RING domains of BRCA1-BARD1 complex and its relevance to the prognosis of breast cancer.
    Kiewhuo K; Priyadarsinee L; Sarma H; Sastry GN
    J Biomol Struct Dyn; 2023; 41(22):12734-12752. PubMed ID: 36775657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis.
    Salas-Lloret D; García-Rodríguez N; Soto-Hidalgo E; González-Vinceiro L; Espejo-Serrano C; Giebel L; Mateos-Martín ML; de Ru AH; van Veelen PA; Huertas P; Vertegaal ACO; González-Prieto R
    Nat Commun; 2024 May; 15(1):4292. PubMed ID: 38769345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/BARD1 intrinsically disordered regions facilitate chromatin recruitment and ubiquitylation.
    Witus SR; Tuttle LM; Li W; Zelter A; Wang M; Kermoade KE; Wilburn DB; Davis TN; Brzovic PS; Zhao W; Klevit RE
    EMBO J; 2023 Aug; 42(15):e113565. PubMed ID: 37305927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.
    Minten EV; Kapoor-Vazirani P; Li C; Zhang H; Balakrishnan K; Yu DS
    Cell Rep; 2021 Mar; 34(13):108921. PubMed ID: 33789098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.
    Wu-Baer F; Ludwig T; Baer R
    Mol Cell Biol; 2010 Jun; 30(11):2787-98. PubMed ID: 20351172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of centrosomes by the BRCA1-dependent ubiquitin ligase.
    Kais Z; Parvin JD
    Cancer Biol Ther; 2008 Oct; 7(10):1540-3. PubMed ID: 18927495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol to detect OLA1 polyubiquitination by Aurora A in vivo and in vitro.
    Fang Z; Li X; Yoshino Y; Chiba N
    STAR Protoc; 2024 Jun; 5(2):103008. PubMed ID: 38602870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it a wrap? Nucleosome interactions of the BRCA1-binding partner, BARD1, steal the scene.
    Morris JR
    Nat Struct Mol Biol; 2021 Sep; 28(9):708-710. PubMed ID: 34518696
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural analysis of BRCA1 reveals modification hotspot.
    Liang Y; Dearnaley WJ; Varano AC; Winton CE; Gilmore BL; Alden NA; Sheng Z; Kelly DF
    Sci Adv; 2017 Sep; 3(9):e1701386. PubMed ID: 28948225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KSR1 regulates BRCA1 degradation and inhibits breast cancer growth.
    Stebbing J; Zhang H; Xu Y; Lit LC; Green AR; Grothey A; Lombardo Y; Periyasamy M; Blighe K; Zhang W; Shaw JA; Ellis IO; Lenz HJ; Giamas G
    Oncogene; 2015 Apr; 34(16):2103-14. PubMed ID: 24909178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WDR5, BRCA1, and BARD1 Co-regulate the DNA Damage Response and Modulate the Mesenchymal-to-Epithelial Transition during Early Reprogramming.
    Peñalosa-Ruiz G; Bousgouni V; Gerlach JP; Waarlo S; van de Ven JV; Veenstra TE; Silva JCR; van Heeringen SJ; Bakal C; Mulder KW; Veenstra GJC
    Stem Cell Reports; 2019 Apr; 12(4):743-756. PubMed ID: 30880078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 p17 matrix protein enhances type I interferon responses through the p17-OLA1-STING axis.
    Zhang L; Li S; Xu X; Ma C; Zhang P; Ji W; Liu X
    J Cell Sci; 2024 Jan; 137(2):. PubMed ID: 38132845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OLA1 Phosphorylation Governs the Mitochondrial Bioenergetic Function of Pulmonary Vascular Cells.
    Sidlowski P; Czerwinski A; Liu Y; Liu P; Teng RJ; Kumar S; Wells C; Pritchard K; Konduri GG; Afolayan AJ
    Am J Respir Cell Mol Biol; 2023 Apr; 68(4):395-405. PubMed ID: 36481055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for BRCA1 in regulating breast cancer cell spreading and motility.
    Coene ED; Gadelha C; White N; Malhas A; Thomas B; Shaw M; Vaux DJ
    J Cell Biol; 2011 Feb; 192(3):497-512. PubMed ID: 21282464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and development of Tetra-ARMS PCR-based screening test for a genetic variant of OLA1 (Tyr254Cys) in the human failing heart.
    Dubey PK; Dubey S; Singh S; Bhat PD; Pogwizd S; Krishnamurthy P
    PLoS One; 2024; 19(6):e0293105. PubMed ID: 38889130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and development of Tetra-ARMS PCR-based screening test for a genetic variant of OLA1 (Tyr254Cys) in the human failing heart.
    Dubey PK; Dubey S; Singh S; Bhat PD; Pogwizd S; Krishnamurthy P
    medRxiv; 2023 Oct; ():. PubMed ID: 37905026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer.
    Liu J; Huang J; Lu J; Ouyang R; Xu W; Zhang J; Chen-Xiao K; Wu C; Shang D; Go VLWB; Guo J; Xiao GG
    iScience; 2024 Jun; 27(6):110027. PubMed ID: 38883822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.